Findings presented at the 33rd European Congress on Obesity in Istanbul, Turkey, on May 15th, have provided a crucial comparative…
Read More

Findings presented at the 33rd European Congress on Obesity in Istanbul, Turkey, on May 15th, have provided a crucial comparative…
Read More
The leadership void at the U.S. Food and Drug Administration (FDA) has prompted a significant groundswell of support from the…
Read More
AstraZeneca’s groundbreaking targeted therapy, Imfinzi (durvalumab), has secured a pivotal recommendation from the National Institute for Health and Care Excellence…
Read More
The political landscape of the United Kingdom has been significantly reshaped by the dramatic resignation of Wes Streeting, the UK…
Read More
On May 13, 2024, at the 33rd European Congress on Obesity (ECO) held in Istanbul, Türkiye, groundbreaking Phase 3b trial…
Read More
The U.S. Food and Drug Administration (FDA) has authorized four significant new cancer drugs in May 2026, marking a pivotal…
Read More
AI drug design and development firm Isomorphic Labs has successfully closed a significant $2.1 billion Series B funding round, marking…
Read More
The United Arab Emirates has achieved a significant milestone in pharmaceutical innovation with the Emirates Drug Establishment (EDE) granting regulatory…
Read More
On 12 May 2026, at the 33rd European Congress on Obesity (ECO) in Istanbul, Türkiye, groundbreaking findings from the Phase…
Read More
The European Union (EU) has achieved a significant legislative milestone with the provisional agreement on the Critical Medicines Act (CMA),…
Read More